DexCare company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former DexCare executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Products & Services
Virtual Care Delivery
Description: White-labeled virtual care platform providing phone and video telehealth services with intelligent provider matching and capacity scaling.••••: ••••••• ••••••••, ••••••• ••••••••, ••••••• ••••••• ••••••••••• ••••: •••• •• •••••• ••••••• •• ••••••• ••/• ••••••• •••• •••••••••, •••• ••••••••• •••• ••••••••• •••••• •••••• ••••• •••••• ••• ••••• •• •••••• •••••• ••• ••••••• •••••••• •••••••••••• ••••••••: ••••-•••••••• ••••••• •••••••••, ••••••• ••••••••••, •••••-••••••• •••••••••, ••••• ••• ••••• ••••••••••••
Digital Care Merchandising
Description: E-commerce-style merchandising platform that enhances service discoverability and routes patients to best-fit care options through a unif••• ••••••• ••••• ••••.••••: ••••••••••••• •••• •••••••, ••••••• •••••••••, •••• •••••••• ••••: •••• •• •••••• ••••••• ••••••• •• ••••••• ••••••• ••••••••••••••• ••• ••••••• ••••••• •••••••••• •• ••••••••••• •••• •••••••••• ••••••••: ••••••-••••• ••••••• ••••••••••, •••••••• •••••••••••, •••••••••• ••••••••••••, •••••• •••••••••••
Care Access Orchestration Platform
Description: Core platform that aggregates digital patient demand, balances provider capacity, and orchestrates scheduling across multiple service lin•• ••• •••• •••••••• •• •••• ••••.••••: ••••••• •••• •••••••••••••, ••••••• ••••••••, •••• •••••••••••••••• ••••: •••• •• ••••• •••••• ••••••• •• •••• ••••••• ••••••• •••••• •••••• ••••••••• ••••••••• ••• ••••••••, •••••••• •••••••• ••••••• ••• •••••••••• •••••••• •••••••••••••• ••••••••: ••••-•••• •••••• •••••••••••, ••••••••••• •••••••, ••••••••••• •••••••, ••• •••••••••••, •••••-••••• •••• ••••••••••••
Pricing & Go-to-market
Typical Contract Length
•••••-•••• •••••••••
Pricing model
Standard subscription model negotiated per service line at each customer with additional charges for visits booked, utilizing a typical land-and-expan• •••••••• •••••• •••• •••••• ••••••. •••••-•••• •••••• ••••••••• ••••••• •••••• •••-••• ••• •••••, •••••••• ••••••••• •• ••••• •••• ••• ••••••• •••• ••• •••••• •• •••••••••• ••••• •••• ••••••••• ••••, •••••• ••••, ••• ••••••• ••••
Average Sales Value
The biggest contracts are in the low 8 figures, most contracts are in the low to mid 7 figures, and the smallest customers may be around $500,000 or s•
Average Sales Cycle
••••• •••••• ••• •••••••••• •••••••••• ••• •••••• •••• • •••• •• ••••
Growth Review
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
 DexCare | - | ••• '•• | - | V•••••••• | |
 MD Live by Evernorth | - | - | - | - | - |
| MD Live by Evernorth | - | - | - | - | - |
 Phreesia | - | - | - | - | P••••• |
| Phreesia | - | - | - | - | P••••• |
 Luma Health | - | - | - | - | P•••••••• |
| Luma Health | - | - | - | - | P•••••••• |
Experts highlight DexCare's operational execution and market approach, while noting capital efficiency requirements as a potential constraint.
What does Origin provide on DexCare?
Origin provides a structured company snapshot of DexCare, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of DexCare different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how DexCare operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like DexCare?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like DexCare for investment, partnership, or competitive analysis.
Where does Origin's information on DexCare come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on DexCare?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to DexCare. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing DexCare?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like DexCare.
How do teams use Origin to evaluate VC-backed companies like DexCare?
For VC-backed companies, Origin is often used to assess product differentiation, early go-to-market motion, buyer behaviour, and the credibility of growth narratives. It can help teams understand where DexCare is winning, what is driving adoption, and which constraints may affect scaling.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like DexCare?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like DexCare, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
DataZymes
Data management and analytics platform with supporting services for pharmaceutical and life sciences companies to manage commercial data, apply predictive analytics, and support go-to-market decision-making.
HQ
Ownership
Aetion
Real-world evidence analytics platform for biopharmaceutical companies, payers, and regulators to generate evidence on treatment safety, effectiveness, and value.